share_log

Spero Therapeutics | 8-K: Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update

SEC announcement ·  May 15 16:19
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more